Novel non-cystic features of polycystic kidney disease: having new eyes or seeking new landscapes
Open Access
- 7 September 2020
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 14 (3) , 746-755
Abstract
For decades, researchers have been trying to decipher the complex pathophysiology of autosomal dominant polycystic kidney disease (ADPKD). So far these efforts have led to clinical trials with different candidate treatments, with tolvaptan being the only molecule that has gained approval for this indication. As end-stage kidney disease due to ADPKD has a substantial impact on health expenditures worldwide, it is likely that new drugs targeting kidney function will be developed. On the other hand, recent clinical observations and experimental data, including PKD knockout models in various cell types, have revealed unexpected involvement of many other organs and cell systems of variable severity. These novel non-cystic features, some of which, such as lymphopenia and an increased risk to develop infections, should be validated or further explored and might open new avenues for better risk stratification and a more tailored approach. New insights into the aberrant pathways involved with abnormal expression of PKD gene products polycystin-1 and -2 could, for instance, lead to a more directed approach towards early-onset endothelial dysfunction and subsequent cardiovascular disease. Furthermore, a better understanding of cellular pathways in PKD that can explain the propensity to develop certain types of cancer can guide post-transplant immunosuppressive and prophylactic strategies. In the following review article we will systematically discuss recently discovered non-cystic features of PKD and not well-established characteristics. Overall, this knowledge could enable us to improve the outcome of PKD patients apart from ongoing efforts to slow down cyst growth and attenuate kidney function decline.Keywords
This publication has 124 references indexed in Scilit:
- Autosomal Dominant Polycystic Kidney Disease: Prevalence of Renal Neoplasias in Surgical Kidney SpecimensNephron Clinical Practice, 2013
- Chronic asymptomatic pyuria precedes overt urinary tract infection and deterioration of renal function in autosomal dominant polycystic kidney diseaseBMC Nephrology, 2013
- Roles of the immune system in skin cancerBritish Journal of Dermatology, 2011
- Conditional Disruption of Pkd1 in Osteoblasts Results in Osteopenia Due to Direct Impairment of Bone FormationJournal of Biological Chemistry, 2010
- Prevalence of Renal Cell Carcinoma in Patients With Autosomal Dominant Polycystic Kidney Disease and Chronic Renal FailureUrology, 2009
- Characterization of Primary Cilia in Human Airway Smooth Muscle CellsChest, 2009
- Coronary Flow Velocity Reserve and Carotid Intima Media Thickness in Patients with Autosomal Dominant Polycystic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2008
- Involvement of Hypoxia-Inducible Transcription Factors in Polycystic Kidney DiseaseThe American Journal of Pathology, 2007
- Skin cancer in organ transplant recipients: Effect of pretransplant end-organ diseaseJournal of the American Academy of Dermatology, 2005
- Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case-control studyNephrology Dialysis Transplantation, 1996